WallStreetZenWallStreetZen

NASDAQ: BIOR
Biora Therapeutics Inc Stock Ownership - Who owns Biora Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Biora Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric DesparbesChief Financial Officer2023-08-1540,022$3.14
$125.67kSell
Aditya P. MohantyChief Executive Officer2023-08-15117,881$3.14
$370.15kSell
Clarke NeumannSenior Vice President General Counsel and Secretary2023-08-1536,183$3.14
$113.61kSell
Eric DesparbesChief Financial Officer2023-05-152,807$3.35
$9.40kSell
Aditya P. MohantyChief Executive Officer2023-05-1511,249$3.35
$37.68kSell
Clarke NeumannSenior Vice President General Counsel and Secretary2023-05-152,368$3.35
$7.93kSell

1 of 1

BIOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIOR insiders and whales buy or sell their stock.

BIOR Shareholders

What type of owners hold Biora Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Athyrium Capital Management LP120.07%36,396,907$22.06MInsider
Athyrium Opportunities Fund A LP120.07%36,396,907$22.06MInsider
Harry Stylli48.88%14,816,522$8.98MInsider
Athyrium Opportunities Iii Coinvest 1 LP36.06%10,929,763$6.62MInsider
Athyrium Capital Management LP36.06%10,929,762$6.62MInstitution
Aditya P. Mohanty5.08%1,539,492$932.93kInsider
Eric Desparbes1.99%603,662$365.82kInsider
Vanguard Group Inc1.68%507,935$307.81kInstitution
Clarke Neumann1.62%492,193$298.27kInsider
Damon Silvestry0.96%291,499$176.65kInsider

1 of 3

BIOR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIOR10.45%89.55%Net Selling
APTO7.58%67.78%Net Buying
TCRT53.36%46.64%Net Selling
AKTX0.00%55.06%
BIVI3.68%96.32%Net Selling
View Top Biotech Stocks

Biora Therapeutics Stock Ownership FAQ

Who owns Biora Therapeutics?

Biora Therapeutics (NASDAQ: BIOR) is owned by 39.26% institutional shareholders, 336.51% Biora Therapeutics insiders, and 0.00% retail investors. Athyrium Capital Management LP is the largest individual Biora Therapeutics shareholder, owning 36.40M shares representing 120.07% of the company. Athyrium Capital Management LP's Biora Therapeutics shares are currently valued at $23.26M.

If you're new to stock investing, here's how to buy Biora Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.